NOMAD POWER SOLUTIONS, INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
NOMAD POWER SOLUTIONS, INC. (NMAD) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $35.84 million as of 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2025-03-24
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $35.84M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $32.62M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $28.04M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $23.29M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2024-12-31 | $35.84M 10-K · filed 2025-03-24 |
| 2023-12-31 | $32.62M 10-K · filed 2024-03-19 |
| 2022-12-31 | $28.04M 10-K · filed 2023-03-29 |
| 2021-12-31 | $23.29M 10-K · filed 2022-03-21 |
| 2020-12-31 | $20.09M 10-K · filed 2021-03-26 |
| 2019-12-31 | $17.99M 10-K · filed 2020-03-25 |
| 2018-12-31 | $16.29M 10-K · filed 2019-03-25 |
| 2017-12-31 | $14.22M 10-K · filed 2018-03-23 |
| 2016-12-31 | $10.61M 10-K · filed 2017-03-29 |
| 2015-12-31 | $11.04M 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |